Please assess the completion status of the following clinical trial:

Trial Title: Safety and Effectiveness of Sculptra Aesthetic for Correction of Cheek Wrinkles

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Intent to undergo correction of cheek wrinkles on both sides of the face and a Galderma Cheek Wrinkles Scale (GCWS) At Rest score of Moderate or Severe on EACH side of the face.~Exclusion Criteria:~* Known/previous allergy or hypersensitivity to any of the Sculptra Aesthetic constituents.~* Previous tissue augmenting therapy, contouring or revitalization treatment in the face, except the lips, with any of the following fillers prior to Baseline visit:~  1. Collagen, Hyaluronic Acid - 12 months~ 2. Calcium Hydroxyapatite (CaHa), Poly L- Lactic Acid (PLLA) or permanent (nonbiodegradable)- Prohibited

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Control Group: No-treatment (Type: NO_INTERVENTION): Participants will receive no treatment during the study.
- Treatment Group: Sculptra Aesthetic (Type: EXPERIMENTAL): Participants will be injected with Sculptra Aesthetic by Treating Investigator at Day 1 until optimal correction achieved (up to 4 total treatment sessions)

Based on this trial design, predict the completion outcome and termination type (if applicable).